Analysis

Telomir Pharmaceuticals, Inc. (TELO) Stock Analysis

Telomir Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to TELO.

websiteTELO/analysis/TELO

Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to TELO.

Stock profile

Ticker

TELO

Asset type

Stock

Market cap

$97.7M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Telomir Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • TELO primary listing

Latest Telomir Pharmaceuticals, Inc. news

Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensiti...

Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Ty...

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefi...

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's

Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical Center. MIAMI, FL / ACCESS Newswire / April 30, 2026 /Telomir Ph...

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)

Transaction establishes global ownership rights of lead program and includes initial capital funding with additional optional milestone-based capital support

Research sections

Valuation

Review valuation context for Telomir Pharmaceuticals, Inc..

Future growth

Review future growth context for Telomir Pharmaceuticals, Inc..

Past performance

Review past performance context for Telomir Pharmaceuticals, Inc..

Financial health

Review financial health context for Telomir Pharmaceuticals, Inc..

Dividend

Review dividend context for Telomir Pharmaceuticals, Inc..

Management

Review management context for Telomir Pharmaceuticals, Inc..

Ownership

Review ownership context for Telomir Pharmaceuticals, Inc..

Other information

Review other information context for Telomir Pharmaceuticals, Inc..

Community

Review community context for Telomir Pharmaceuticals, Inc..